Preview Mode Links will not work in preview mode

Move the human story forward!™ ideaXme.

The humans behind the big ideas that shape our world. Help and inspiration for future creators and for all those who love big ideas and great stories.

 

Step into the world of creators!

 

 

ideaXme is a podcast, ambassador and mentor programme.

We want to involve everyone in creating the big ideas that shape our world.

Radio ideaXme iTunes, ideaXme Spotify and ideaXme SoundCloud are destinations for ideaXme's audio interviews.

Video interviews: ideaXme YouTube

 

 

 

Feb 26, 2019

How to fight aging? Ira Pastor founder of Bioquark and ideaXme Longevity and Aging ambassador interviews Dr. Marios Kyriazis, a biomedical gerontologist, candidate for the Nobel Prize in Medicine 2017, medical doctor and founder of ELPIs Foundation for Indefinite Lifespans.

Ira Pastor ideaXme Longevity and Aging ambassador and Marios Kyriazis founder ELPIs Foundation

Fighting aging

Ira Pastor comments:


Feb 26, 2019

"I would say that individuals born in the second half of the 21 century could live for centuries in quite good health." Professor Michael Rose. Discover the scientific theory behind his hypothesis to banish aging.

Ira Pastor and Professor Michael Rose, University of California, Irvine

The interview: How to banish aging

Ira Pastor, ideaXme Longevity and Aging ambassador and...


Feb 26, 2019

Ira Pastor ideaXme Longevity and Aging ambassador and founder of Bioquark interviews Dr John (Jose) Mejia, MD and founder of Ectocrine Technologies to evaluate mosquitoes as a drug delivery system and their saliva offering potential to cure human disease.

Ira Pastor comments:

Could we eradicate many diseases with...


Feb 6, 2019

Ira Pastor founder of Bioquark and ideaXme Longevity and Aging ambassador interviews Dr Michael Lustgarten author Microbial Burden.

Ira Pastor:

Throughout the 20th century, natural products (primarily those from plants, fungi, and bacteria) formed the basis for a majority of pharmaceuticals, biologics, and...